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Background
Catheter-based ablation techniques are widely applied in
the restoration of sinus rhythm. The latter may result in
an improvement of left heart function in patients with
atrial fibrillation (AF). Cardiovascular magnetic reso-
nance (CMR) feature tracking (FT) might help detect
subtle wall-motion abnormalities. We aimed to analyze
existence and reversibility of subtle cardiac dysfunction
following atrial fibrillation ablation.
Methods
We studied 28 consecutive patients (mean age: 61 years)
with paroxysmal AF who underwent pulmonary vein
isolation (PVI). CMR imaging was done 3 (± 3) days
before and 3.4 (± 1.1) months after ablation. FT analysis
was performed in order to assess left heart function.
Three-dimensional peak velocities, strain, strain rate and
torsion were measured before ablation and compared to
post ablation. Systolic peaks were separated from diasto-
lic reverse peaks in order to better evaluate left heart
function (See Figure 1). A meta-analysis was performed
to compare published healthy volunteers’ tracking data
to our patients before AF ablation. Statistical analysis
included paired student’s t-test and random effects
metaanalysis and Bland-Altman analysis.
Results
17 patients (61%) were free from AF at follow-up. Bland-
Altman analysis showed good coefficients of variation.
Of all 195 parameters, 27 changed (14%): 9 improved sig-
nificantly (5%), 12 worsened significantly (6%), whereas
6 parameters worsened not significantly (3%). 18 of 120
systolic parameters changed (15%), 14 worsened (12%),
4 improved (3%). In 9 of 75 diastolic parameters, values
changed (12%): 5 improved (7%) and 4 worsened (5%).
Meta-analysis revealed that our collective’s FT values at
baseline did not differ significantly from healthy volun-
teers’ values (Q values of 0.01 [p value 0.921] and 1.499
[p value 0.221]).
Conclusions
AF patients undergoing ablation appear to have near nor-
mal cardiac wall motion, which does not improve follow-
ing successful ablation. Feature tracking analysis is a
reliable tool to determine treatment effects but is more
likely to show positive findings if the population is
unhealthy.
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